The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Maraganore John since year 2005.
The trader's CIK number is 1180432.
At the time of this reporting, Maraganore John is the CEO of Alnylam Pharmaceuticals, Inc. .
(stock ticker symbol ALNY).
See this page for all insider trading activities at Alnylam Pharmaceuticals, Inc. .
Stock purchases, sales, and option exercises reported by insider Maraganore John since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-08-18
ALNY
Alnylam Pharmaceuticals, Inc.
Option Exercise
750
.48
356
2008-08-13
ALNY
Alnylam Pharmaceuticals, Inc.
Option Exercise
37,500
.48
17,812
2008-08-14
ALNY
Alnylam Pharmaceuticals, Inc.
Option Exercise
37,500
.48
17,812
2008-08-13
ALNY
Alnylam Pharmaceuticals, Inc.
Sale
37,500
33.95
1,273,005
2008-08-14
ALNY
Alnylam Pharmaceuticals, Inc.
Sale
37,500
34.23
1,283,512
2008-06-30
ALNY
Alnylam Pharmaceuticals, Inc.
Option Exercise
3,000
.48
1,425
2007-06-29
ALNY
Alnylam Pharmaceuticals, Inc.
Sale
17,089
15.83
270,553
2007-06-29
ALNY
Alnylam Pharmaceuticals, Inc.
Sale
1,689
16.20
27,366
2007-06-28
ALNY
Alnylam Pharmaceuticals, Inc.
Option Exercise
37,500
.48
17,812
2007-06-28
ALNY
Alnylam Pharmaceuticals, Inc.
Sale
20,069
15.92
319,515
2007-06-28
ALNY
Alnylam Pharmaceuticals, Inc.
Sale
17,431
16.11
280,781
2007-06-29
ALNY
Alnylam Pharmaceuticals, Inc.
Option Exercise
37,500
.48
17,812
2007-06-29
ALNY
Alnylam Pharmaceuticals, Inc.
Sale
18,722
15.40
288,254
2006-05-15
ALNY
Alnylam Pharmaceuticals, Inc.
Option Exercise
37,500
.48
17,812
2006-05-15
ALNY
Alnylam Pharmaceuticals, Inc.
Sale
41,635
15.08
627,684
2006-05-16
ALNY
Alnylam Pharmaceuticals, Inc.
Sale
1,000
15.05
15,050
2006-05-12
ALNY
Alnylam Pharmaceuticals, Inc.
Option Exercise
37,500
.48
17,812
2006-05-12
ALNY
Alnylam Pharmaceuticals, Inc.
Sale
28,313
15.20
430,328
2006-05-12
ALNY
Alnylam Pharmaceuticals, Inc.
Sale
13,322
15.72
209,399
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Maraganore John
(CEO of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
